Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.3850

-0.0451 (-10.49%)

At close: Jun 2, 2025, 4:00 PM

0.3815

-0.0035 (-0.91%)

After-hours: Jun 2, 2025, 7:06 PM EDT

Aspire Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	1.35	0	0.01	0
Cash & Short-Term Investments	1.35	0	0.01	0
Cash Growth	11950.68%	-67.49%	29305.26%	-
Prepaid Expenses	0.62	0.14	0.04	0.02
Total Current Assets	1.97	0.15	0.05	0.02
Total Assets	1.97	0.15	0.05	0.02
Accounts Payable	1.43	0.31	0.17	0.12
Short-Term Debt	6.76	1.27	0.36	0.03
Other Current Liabilities	-	0.11	0	0
Total Current Liabilities	8.87	1.69	0.53	0.15
Other Long-Term Liabilities	0.05	-	-	0
Total Liabilities	8.92	1.69	0.53	0.15
Common Stock	0	0.02	0.02	0.22
Additional Paid-In Capital	11.76	1.22	0.96	0.76
Retained Earnings	-18.72	-2.78	-1.47	-1.11
Total Common Equity	-6.95	-1.54	-0.49	-0.13
Shareholders' Equity	-6.95	-1.54	-0.49	-0.13
Total Liabilities & Equity	1.97	0.15	0.05	0.02
Total Debt	6.76	1.27	0.36	0.03
Net Cash (Debt)	-5.42	-1.26	-0.35	-0.03
Net Cash Per Share	-0.11	-0.00	-0.00	-
Filing Date Shares Outstanding	48.9	440	443.32	-
Total Common Shares Outstanding	48.9	440	443	-
Working Capital	-6.9	-1.54	-0.49	-0.13
Book Value Per Share	-0.14	-0.00	-0.00	-
Tangible Book Value	-6.95	-1.54	-0.49	-0.13
Tangible Book Value Per Share	-0.14	-0.00	-0.00	-

Updated Jan 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.